PGNY

Progyny, Inc.

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.

Progyny, Inc. (PGNY) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 C+ (2.8) C+ (2.8) B- (2.9) B+ (3.8) C+ (2.6) B- (3.0)
2026-11-07 C+ (2.8) C+ (2.7) B- (2.9) B+ (3.8) C+ (2.7) B- (3.0)
2026-10-31 B- (2.9) C (2.4) C+ (2.8) B- (3.1) C+ (2.7) C+ (2.8)
2026-10-24 B- (2.9) C (2.4) C+ (2.8) B- (3.1) F (0.0) C (2.3)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe